https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

A study by IDIVAL proposes a useful tool to improve candidate selection for lung transplantation

23 de April de 2025

The research, conducted by professionals from the Marqués de Valdecilla University Hospital and researchers from the IDIVAL Health Research Institute, evaluates the usefulness of the GAP index as a prognostic marker in patients with interstitial lung diseases referred for transplantation. Researchers from the Marqués de Valdecilla Research Institute (IDIVAL), in collaboration with the Pulmonology Department […]

Read more →

What Can Bone Tell Us About the Risk of Contracting COVID-19? A Study from Cantabria Explores the Connection Between Bone Metabolism and SARS-CoV-2 Infection

21 de April de 2025

A team from the Immunopathology Group at IDIVAL, the University of Cantabria, and the Cantabrian Health Service has discovered a relationship between bone metabolism and vulnerability to SARS-CoV-2. The study, led by Drs. Emilio Pariente and José Luis Hernández, was recently published in the scientific journal Current Medical Research and Opinion and sheds light on […]

Read more →

IDIVAL welcomes representatives from CRG and the Pasqual Maragall Foundation to explore avenues for collaboration in biomedical research

16 de April de 2025

This Monday, the Marqués de Valdecilla Research Institute (IDIVAL) welcomed Glòria Oliver Rodríguez, Deputy Director General of the Pasqual Maragall Foundation, and Joan Vives i Tomàs, Administrative Director of the Centre for Genomic Regulation (CRG). During their visit to IDIVAL’s headquarters in Santander, they held a meeting with Galo Peralta Fernández, Managing Director, Marcos López […]

Read more →

Researchers from IDIVAL and the University of Cantabria develop an AI that predicts cardiac recovery after valve surgery with 90% accuracy

9 de April de 2025

The project Transcriptomics and artificial intelligence for predicting adverse cardiac remodeling in patients undergoing surgery for aortic valve stenosis, funded by the INNVAL 2021 call from the Marqués de Valdecilla Research Institute (IDIVAL), has focused on studying omics data from left ventricle biopsies of patients with severe aortic stenosis who underwent valve replacement surgery at […]

Read more →

IDIVAL Researchers Explore a New Drug Combination for Chronic Lymphocytic Leukaemia

27 de March de 2025

Chronic lymphocytic leukaemia (CLL) is one of the most common haematological diseases in older adults, with a higher incidence in men than in women. Despite advances in treatment, it remains an incurable disease, and patients eventually develop resistance to available therapies. In this context, a team of researchers led by Carlos Pipaón, from the Haematological […]

Read more →

IDIVAL Joins the European Joint Action JADE Health to Advance Dementia Prevention and Treatment

24 de March de 2025

The Valdecilla Health Research Institute (IDIVAL) is participating as an associate entity in the European project JADE Health (Joint Action on Dementia and Health System Sustainability), a joint action funded by the European Commission under the EU4Health program. This initiative, which brings together institutions from various European countries, aims to improve prevention, early diagnosis, and […]

Read more →

Workshop: “Mobility in Access to Health Services”.

5 de March de 2025

On February 14, 2025, a workshop was held at IDIVAL’s LiNNUX Lab, in collaboration with FISABIO and with the participation of LASINDE. Under the title “How can we improve healthcare mobility in Cantabria?”, the event brought together healthcare professionals, innovation experts and health service users, who contributed valuable ideas and perspectives on the topic. The […]

Read more →

Cantabria Cohort Surpasses 45,000 Volunteers and Enters the Final Stage of Its Recruitment Phase

4 de March de 2025

Next month, the largest biomedical research project in Cantabria, a pioneering initiative in Spain, will mark four years of progress and is now on the verge of reaching its initial goal of 50,000 participants. Cantabria Cohort has already surpassed 45,000 volunteers, entering the final stage of its recruitment phase. This major biomedical research project, a […]

Read more →

IDIVAL launches two free online courses to improve cardiovascular health and diabetes prevention and management in Cantabria

18 de February de 2025

The Valdecilla Health Research Institute (IDIVAL), through its Nursing Research Group, is launching two free online courses as part of the European JACARDI project (Joint Action on Cardiovascular Diseases and Diabetes). These trainings, endorsed by the Cantabrian Health Service, are designed to promote self-care and health literacy among the population. The JACARDI project aims to […]

Read more →

A new approach to combat osteoporosis: mesenchymal stem cell secretome as a regenerative therapy

13 de February de 2025

Researchers from the Skeletal, Metabolic, and Environmental Diseases Group (iESQUEMA) from the IDIVAL, have developed a new approach based on the secretome of mesenchymal stem cells (MSCs) as a therapeutic strategy for osteoporosis. This work, recently published in Stem Cell Research & Therapy, demonstrates that a single administration of a secretome, modified to enhance its […]

Read more →
Idival
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.